US Patent 7683030 Methods of treating diabetes with albumin-conjugated exendin peptides
Patent 7683030 was granted and assigned to Amylin Pharmaceuticals on March, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 1 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+484 characters)
Article
Patent abstract
Modified exendins and exendin agonists having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, and related formulations and dosages and methods of administration thereof are provided. These modified exendins and exendin agonists, compositions and methods are useful in treating diabetes and conditions that would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying or inhibiting food intake.
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07683030 Methods of treating diabetes with albumin-conjugated exendin peptides US Patent 7683030 Methods of treating diabetes with albumin-conjugated exendin peptides
Infobox
Patent Number
0768303000
Patent Number
768303000
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076830300
Date of Patent
March 23, 2010
0Patent Application Number
120460380
Date Filed
March 11, 2008
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076830300
Date of Patent
March 23, 2010
0Patent Application Number
120460380
Date Filed
March 11, 2008
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07683030 Methods of treating diabetes with albumin-conjugated exendin peptides
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07683030
Date of patent
March 23, 2010
Patent application number
12046038
Date Filed
March 11, 2008
Patent primary examiner
Find more entities like US Patent 7683030 Methods of treating diabetes with albumin-conjugated exendin peptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.